OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
18
Results
Show all
Save search
Copy query
Show results for
Unknown
(18)
Publication Date
Release Date
2025
(4)
2021
(4)
2020
(4)
2024
(2)
2019
(2)
2023
(1)
2022
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Single-cell RNA sequencing reveals the tumor microenvironment and facilitates strategic choices to circumvent treatment failure in a chemorefractory bladder cancer patient.
Not available
S-EPMC7251908
|
biostudies-literature
Cite
Impacts of baseline biomarkers on cognitive trajectories in subjective cognitive decline: the CoSCo prospective cohort study.
Not available
S-EPMC10405399
|
biostudies-literature
Cite
EEG-based detection of early functional brain changes in subjective cognitive decline: a prospective cohort study.
Not available
S-EPMC12751729
|
biostudies-literature
Cite
Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients.
Not available
S-EPMC7494149
|
biostudies-literature
Cite
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
Not available
S-EPMC12535838
|
biostudies-literature
Cite
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
Not available
S-EPMC12535840
|
biostudies-literature
Cite
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023.
Not available
S-EPMC12535839
|
biostudies-literature
Cite
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.
Not available
S-EPMC6619057
|
biostudies-literature
Cite
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension.
Not available
S-EPMC7905790
|
biostudies-literature
Cite
Consistent improvement with eculizumab across muscle groups in myasthenia gravis.
Not available
S-EPMC7448154
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets